Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Allogene Therapeutics, Inc. ALLO

Set alert

Price alert · ALLO

All alert types
1.11 USD +0.02 +1.83%

As of Nov 3, 1:33 PM ET

Bid
1.11 × 5
Ask
1.12 × 3
1.10 Day range 1.14
1.04 52-week range 4.46
YTD
-18.98%
1 year
-5.93%
Open
1.12
Prev close
1.09
Mkt cap
385.22M
Vol
12.73M
Avg vol
5.99M
EPS
-0.66
P/E
0.00
Div yield
0.00%
More statistics
Low
1.10
High
1.14
Forward P/E
-1.50
Beta
0.84
Short ratio
11.46
Inst. own
80.20%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2024
50-d avg
2.47
200-d avg
2.83
1y target
9.04

3M chart

Chart tools
Interval
1m5m15m30m

Signals (10)
NameDateAgo
MACD: Sell SignalNov 2, 20261 day ago
RSI: OversoldOct 30, 20264 days ago
MACD: Buy SignalOct 27, 20261 week ago
MACD: Sell SignalOct 26, 20261 week ago
RSI: OversoldOct 22, 20261 week ago
MACD: Buy SignalOct 21, 20261 week ago
RSI: OversoldOct 1, 20261 month ago
MACD: Sell SignalAug 28, 20262 months ago
SMA: BullishAug 6, 20262 months ago
SMA: BullishAug 5, 20263 months ago

Financial health

Altman Z-Score

-3.65 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 4

Valuation

P/E -1.6×
FY 2017: -550141×FY 2018: -11.4×FY 2019: -14.2×FY 2020: -12.1×FY 2021: -11.1×FY 2022: -2.6×FY 2023: -1.5×FY 2024: -1.6×FY 2025: -1.6×
FY 2017 5y median -1.6× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 17.8×FY 2022: 5772×FY 2023: 5303×FY 2024: 18861×FY 2025: 0.0×
FY 2017 5y median 5303× FY 2025
P/B 1.0×
FY 2017: -550141×FY 2018: 3.4×FY 2019: 4.2×FY 2020: 2.8×FY 2021: 2.2×FY 2022: 1.4×FY 2023: 1.0×FY 2024: 1.0×FY 2025: 1.0×
FY 2017 5y median 1.0× FY 2025
P/FCF -2.0×
FY 2017: 0.0×FY 2018: -50.4×FY 2019: -14.0×FY 2020: -16.8×FY 2021: -9.8×FY 2022: -4.0×FY 2023: -2.1×FY 2024: -2.1×FY 2025: -2.0×
FY 2017 5y median -2.1× FY 2025
EV/EBITDA -1.9×
FY 2017: 50013×FY 2018: -8.4×FY 2019: -13.9×FY 2020: -12.0×FY 2021: -11.2×FY 2022: -2.9×FY 2023: -1.6×FY 2024: -1.8×FY 2025: -1.9×
FY 2017 5y median -1.9× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 16.9×FY 2022: 6023×FY 2023: 5429×FY 2024: 19568×FY 2025: 0.0×
FY 2017 5y median 5429× FY 2025
FCF Yield -49.5%
FY 2017: 0.0%FY 2018: -2.0%FY 2019: -7.2%FY 2020: -6.0%FY 2021: -10.2%FY 2022: -25.1%FY 2023: -47.5%FY 2024: -48.4%FY 2025: -49.5%
FY 2017 5y median -47.5% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: -9063.5%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 0.0%
FY 2017 5y median 100.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -157.9%FY 2022: -215087.2%FY 2023: -344986.3%FY 2024: -1241813.6%FY 2025: 0.0%
FY 2017 5y median -215087.2% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -159.6%FY 2022: -218214.1%FY 2023: -344489.5%FY 2024: -1170863.6%FY 2025: 0.0%
FY 2017 5y median -218214.1% FY 2025
ROE -65.3%
FY 2017: 100.0%FY 2018: -30.1%FY 2019: -29.3%FY 2020: -23.2%FY 2021: -19.7%FY 2022: -51.0%FY 2023: -63.9%FY 2024: -61.0%FY 2025: -65.3%
FY 2017 5y median -61.0% FY 2025
ROIC -52.8%
FY 2017: 0.0%FY 2018: -25.9%FY 2019: -29.4%FY 2020: -22.7%FY 2021: -17.9%FY 2022: -43.4%FY 2023: -53.5%FY 2024: -52.5%FY 2025: -52.8%
FY 2017 5y median -52.5% FY 2025
ROA -45.9%
FY 2017: 0.0%FY 2018: -27.3%FY 2019: -25.7%FY 2020: -20.4%FY 2021: -17.3%FY 2022: -41.4%FY 2023: -50.9%FY 2024: -46.9%FY 2025: -45.9%
FY 2017 5y median -45.9% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -99.9%FY 2023: -39.1%FY 2024: -76.8%FY 2025: -100.0%
FY 2017 FY 2025
Operating Income 24.3%
FY 2017: 0.0%FY 2018: -9642000.0%FY 2019: -4.8%FY 2020: -27.8%FY 2021: 30.2%FY 2022: -86.2%FY 2023: 2.3%FY 2024: 16.6%FY 2025: 24.3%
FY 2017 FY 2025
EPS (diluted) 34.1%
FY 2017: 0.0%FY 2018: -5193230.5%FY 2019: 22.5%FY 2020: -13.7%FY 2021: 35.6%FY 2022: -77.6%FY 2023: 12.2%FY 2024: 36.8%FY 2025: 34.1%
FY 2017 FY 2025
Free Cash Flow 25.6%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -292.9%FY 2020: 3.8%FY 2021: -13.9%FY 2022: -9.4%FY 2023: -6.0%FY 2024: 16.0%FY 2025: 25.6%
FY 2017 FY 2025

Financial Health

Current Ratio 7.9×
FY 2017: 0.0×FY 2018: 15.9×FY 2019: 16.5×FY 2020: 9.0×FY 2021: 9.8×FY 2022: 9.8×FY 2023: 12.4×FY 2024: 8.5×FY 2025: 7.9×
FY 2017 5y median 9.8× FY 2025
Quick Ratio 7.9×
FY 2017: 0.0×FY 2018: 24.8×FY 2019: 16.5×FY 2020: 9.0×FY 2021: 9.8×FY 2022: 9.8×FY 2023: 12.4×FY 2024: 8.5×FY 2025: 7.9×
FY 2017 5y median 9.8× FY 2025
Debt / Equity 0.3×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.3×
FY 2017 5y median 0.2× FY 2025
Net Debt / EBITDA -0.2×
FY 2017: 0.0×FY 2018: 3.3×FY 2019: 0.7×FY 2020: 0.5×FY 2021: 0.6×FY 2022: -0.1×FY 2023: -0.0×FY 2024: -0.1×FY 2025: -0.2×
FY 2017 5y median -0.1× FY 2025
Interest Coverage -192×
FY 2017: 0.0×FY 2018: -57.4×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -1509×FY 2025: -192×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31